The scope of our recent study, titled "Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)" includes the description of factors fueling the market growth, estimation and forecast of revenue, and identification of significant market players and their key developments. The report also provides a market share analysis.

The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Probiotics are live micro-organisms that promote good digestive health and help to improve human gut health. They play a vital role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Gut health has become one of the prime health concerns among consumers. Increasing awareness regarding the benefits of probiotics has surged their popularity in infant, child, and maternal women health supplements. These factors are significantly driving the global demand for infant, child, and maternal probiotic supplements.

There is a rising prevalence of digestive disorders due to unhealthy consumption habits amongst children. This factor provides the strong potential to the infant, child, and maternal probiotic supplements market.

Based on form, the infant, child, and maternal probiotic supplements market is segmented into capsules and soft gels, gummies, liquid, and others. The others segment held the largest market share in 2020, whereas the gummies segment is projected to register the fastest CAGR during the forecast period. Increased awareness about the benefits of other probiotics, such as longer shelf life and better physicochemical stability compared to liquid forms of dosage, is a major factor driving the others segment.

Moreover, key players in the market are engaged in offering products in other forms, such as lozenges, powder, and others, which is further attributed to the market's growth.

The infant, child, and maternal probiotic supplements market is segmented into 4 main regions: North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). North America held the largest share in the infant, child, and maternal probiotic supplements market in 2020, and Asia Pacific is expected to register the fastest CAGR during the forecast period. Manufacturers and research institutions are continuously investing in research and development activities to develop advanced and reliable products for infants, children, and pregnant women. For instance, in May 2022, the University of Calgary conducted a study stating that probiotic supplements can help form a healthy microbiome in the gut of the tiniest infant, who is not born with a fully formed gut microbiome. Such research and development activities in the region are expected to surge the demand for probiotic supplements for infants, children, and pregnant women in North America.

Moreover, governments of North American countries are taking initiatives to improve infant and children's health. For instance, Healthy Start is one initiative to improve childhood health care. This initiative is designed to reduce the infant mortality rate and improve prenatal health in the region. Hence, the prenatal and postnatal use of probiotic supplements is further surging the growth of the infant, child, and maternal probiotic supplements market across North America.

Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market

Before the onset of the COVID-19 pandemic, the infant, child, and maternal probiotic supplements market was mainly driven by the rising focus of parents on specific infant nutrition coupled with the increasing demand for nutritional supplements tailored according to the needs of pregnant women. However, the market faced unprecedented challenges after the outbreak in 2020. The manufacturers of infant, child, and maternal probiotic supplements faced significant challenges due to supply chain constraints caused by nationwide lockdowns, trade bans, and travel restrictions. Supply chain disruptions created a shortage of raw materials, which affected the production and distribution of various products, leading to increased prices.

Moreover, probiotic strains, especially Bifidobacteria and lactobacillus, have favorable effects on the clearance of influenza viruses. This factor influenced the purchasing decisions of consumers. According to a survey conducted by Fonterra Co-operative, immune health was a stronger driver for purchasing probiotic supplements for infants and children than digestive health in China, Brazil, and the UAE. Thus, the COVID-19 pandemic created a massive demand for infant, child, and maternal probiotic supplements. However, due to the operational difficulties and raw material and labor shortages, there was a shortfall in production volumes, which led to the demand and supply gap. In response to the rising demand, manufacturers with more inventories could meet the demand, while companies with exhausted inventories incurred losses.

The report segments the Infant, Child, and Maternal Probiotic Supplements Market as follows:

Based on form, the market is segmented into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infants and toddlers, children, and maternal women. Based on geography, the market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com